OTCMKTS:PBIO Pressure BioSciences (PBIO) Stock Price, News & Analysis $0.0006 0.00 (0.00%) As of 05/22/2026 03:00 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisChartSEC FilingsBuy This Stock About Pressure BioSciences Stock (OTCMKTS:PBIO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Pressure BioSciences alerts:Sign Up Key Stats Today's Range$0.0006▼$0.000650-Day Range N/A52-Week Range$0.00▼$0.20Volume1,000 shsAverage Volume12,028 shsMarket Capitalization$25.78 thousandP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview Pressure BioSciences, Inc., headquartered in South Easton, Massachusetts, develops and markets novel pressure-based instruments and consumables for sample preparation in the life sciences, biotechnology and pharmaceutical industries. The company’s core innovation, Pressure Cycling Technology (PCT), uses alternating cycles of high hydrostatic pressure to facilitate efficient and reproducible cell disruption, protein extraction and subcellular fractionation. Its flagship Barocycler® instrument has been adopted by researchers working in proteomics, biomarker discovery, vaccine development and pathogen inactivation workflows. In addition to its instrument platform, Pressure BioSciences offers a range of proprietary consumables—including pressure-resistant processing tubes and optimized reagent kits—designed to support diverse sample types such as tissue, microbes and blood derivatives. The company also markets an Ultra Shear Technology (UST) system for high-pressure homogenization, targeting applications in food science, nutraceutical development and personal care product formulation. Pressure BioSciences serves a global customer base through direct sales and distribution partners in North America, Europe and Asia. Its clients include academic and government research institutions, contract research organizations and biotechnology and pharmaceutical companies. Although it operates as a small-cap public company on the OTC markets, the firm has established collaborative relationships with leading research centers and regularly showcases its sample-preparation solutions at scientific conferences and trade exhibitions.AI Generated. May Contain Errors. Read More Receive PBIO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Pressure BioSciences and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. PBIO Stock News HeadlinesPressure BioSciences Partners with Vita-Forte, Largest Global Supplier of Freeze-Dried Acai, to Commercialize Highly Potent, Multi-Antioxidant, UST Nanoemulsion Oral SprayJune 25, 2024 | globenewswire.comPressure BioSciences, Inc. to Host Business and Financial Update on Thursday, June 20th at 4:30pm ETJune 18, 2024 | globenewswire.comRead now. Do not delete. You’ve been warned.Three Nobel Prize Winners expose this once-in-a-generation wealth shift: “Don’t Say I Didn’t Warn You” Porter Stansberry exposes how the convergence of three immense forces is about to rewrite everything about the American way of life: how you work, save, invest… it’s all about to change.May 26 at 1:00 AM | Porter & Company (Ad)Pressure BioSciences, Inc. to Host Business and Financial Update on Wednesday, June 19th at 4:30pm ETJune 13, 2024 | globenewswire.comThe big blood pressure experimentApril 24, 2024 | bbc.co.ukPacBio moved to Neutral at JPMorgan after guidance cutApril 22, 2024 | msn.comPressure BioSciences’ Uncle Bud’s Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”April 2, 2024 | finance.yahoo.comPressure BioSciences' Uncle Bud's Subsidiary Reports Significant Demand for New UltraShear CBD Body Revive Spray – First Product in New “Premium Collection”April 2, 2024 | globenewswire.comSee More Headlines PBIO Stock Analysis - Frequently Asked Questions How have PBIO shares performed this year? Pressure BioSciences' stock was trading at $0.0005 at the beginning of the year. Since then, PBIO shares have increased by 20.0% and is now trading at $0.0006. How were Pressure BioSciences' earnings last quarter? Pressure BioSciences Inc. (OTCMKTS:PBIO) issued its quarterly earnings results on Friday, February, 7th. The company reported ($0.15) earnings per share for the quarter. How do I buy shares of Pressure BioSciences? Shares of PBIO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Pressure BioSciences own? Based on aggregate information from My MarketBeat watchlists, some other companies that Pressure BioSciences investors own include Hydrofarm Holdings Group (HYFM), Advanced Micro Devices (AMD), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP) and Novavax (NVAX). Company Calendar Last Earnings2/07/2025Today5/26/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry MED INSTRUMENTS Sub-IndustryMeasuring And Control Equipment Current SymbolOTCMKTS:PBIO CIK830656 Webwww.pressurebiosciences.com Phone508-230-1828Fax508-230-1829Employees10Year Founded2004Profitability EPS (Trailing Twelve Months)N/A Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$1.98 million Price / Sales0.01 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares42,970,000Free Float38,327,000Market Cap$25.78 thousand OptionableNot Optionable Beta6.15 Social Links A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for June 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.Get This Free Report This page (OTCMKTS:PBIO) was last updated on 5/26/2026 by MarketBeat.com Staff. From Our PartnersThe SpaceX supplier that shipped 5 billion chips to StarlinkWhen Nvidia surged 770%, its data center cooling supplier Vertiv climbed 1,700%. When Apple ran 2,000%, suppli...Weiss Ratings | SponsoredNo. You’re not imagining it…Porter Stansberry, founder of one of the largest financial research firms in the world, says he's breaking the...Porter & Company | SponsoredHey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...Banyan Hill Publishing | SponsoredI was right about SpaceXJeff Brown predicted Bitcoin before it climbed as high as 52,400%, Tesla before 2,150%, and Nvidia before 32,0...Brownstone Research | SponsoredGoldman Sachs just told you what to buy (most people missed it)Goldman Sachs just revealed that 40% of AI data centers will be crippled by electricity shortages by 2027 - no...Behind the Markets | SponsoredYour book attachedBill Poulos is offering his 'Simple Options Trading For Beginners' guide at no cost - normally priced at $29.9...Profits Run | SponsoredNew Warning From Our CEOMarketWise CEO Dr. David 'Doc' Eifrig, a former Goldman Sachs derivatives trader, has released an urgent brief...Stansberry Research | SponsoredI was right about SpaceX. Now here's the part that mattersGoldman Sachs and JP Morgan have already been tied to allocations surrounding the SpaceX deal. When the bigges...The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pressure BioSciences Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Pressure BioSciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
